| |
| |
|
| Insider
Information: |
Corvese Brian |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
457,612 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$40,840 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
457,612 |
|
|
| Total
Value |
$40,840 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Antigenics Inc |
AGEN |
Director |
2021-06-16 |
92,085 |
2018-03-31 |
0 |
Premium* |
|
|
Mink Therapeutics, Inc. |
INKT |
|
2024-03-01 |
365,527 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INKT |
Mink Therapeutics, Inc. |
|
– • – |
2024-03-01 |
4 |
A |
$0.95 |
$17,875 |
D/D |
18,816 |
365,527 |
0 |
- |
|
| INKT |
Mink Therapeutics, Inc. |
|
– • – |
2023-12-01 |
4 |
A |
$1.04 |
$17,876 |
D/D |
17,188 |
346,711 |
0 |
- |
|
| INKT |
Mink Therapeutics, Inc. |
|
– • – |
2023-09-01 |
4 |
A |
$1.46 |
$17,876 |
D/D |
12,244 |
329,523 |
0 |
- |
|
| INKT |
Mink Therapeutics, Inc. |
Director |
– • – |
2023-06-01 |
4 |
A |
$1.76 |
$17,876 |
D/D |
10,157 |
317,505 |
0 |
- |
|
| INKT |
Mink Therapeutics, Inc. |
Director |
– • – |
2023-03-01 |
4 |
A |
$2.09 |
$17,876 |
D/D |
8,553 |
307,348 |
0 |
- |
|
| INKT |
Mink Therapeutics, Inc. |
Director |
– • – |
2022-12-01 |
4 |
A |
$2.61 |
$17,876 |
D/D |
6,849 |
298,795 |
0 |
- |
|
| INKT |
Mink Therapeutics, Inc. |
Director |
– • – |
2022-09-15 |
4 |
A |
$2.62 |
$35,753 |
D/D |
13,646 |
13,646 |
0 |
- |
|
| INKT |
Mink Therapeutics, Inc. |
Director |
– • – |
2021-10-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
278,300 |
|
- |
|
| AGEN |
Antigenics Inc |
Director |
– • – |
2021-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,471 |
92,085 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Director |
– • – |
2020-06-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,118 |
69,614 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Director |
– • – |
2018-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,220 |
21,220 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
